Catalog No. :	CLA1008
Product Name :	Bevacizumab biosimilar
CAS No. :	216974-75-3
Synonyms :	RhuMab VEGF | anti-VEGF
Chemical Name :
Molecular Formula :
Molecular Weight :
Molecular Structure :
Appearance :
Specification :	95+%
Application :	VEFG
Registration :
Storage Condition :	Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles

Bevacizumab biosimilar is vascular endothelial growth factor directed antibody. Bevacizumab biosimilar is a recombinant humanized monoclonal IgG1 antibody that contains human framework regions and murine complementarity-determining regions. Bevacizumab biosimilar has an approximate molecular weight of 149 kDa. Bevacizumab is produced in a mammalian cell (Chinese Hamster Ovary) expression system in a nutrient medium. 

Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.